These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36909308)

  • 1. Association between aberrant amino acid metabolism and nonchromosomal modifications fetal structural anomalies: A cohort study.
    Yuan H; Liu C; Wang X; Huang T; Liu D; Huang S; Wu Z; Liu Y; Yin P; Yang B
    Front Endocrinol (Lausanne); 2023; 14():1072461. PubMed ID: 36909308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study.
    Petrovski S; Aggarwal V; Giordano JL; Stosic M; Wou K; Bier L; Spiegel E; Brennan K; Stong N; Jobanputra V; Ren Z; Zhu X; Mebane C; Nahum O; Wang Q; Kamalakaran S; Malone C; Anyane-Yeboa K; Miller R; Levy B; Goldstein DB; Wapner RJ
    Lancet; 2019 Feb; 393(10173):758-767. PubMed ID: 30712878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 6. A screening test proposal for congenital defects based on maternal serum metabolomics profile.
    Troisi J; Lombardi M; Scala G; Cavallo P; Tayler RS; Symes SJK; Richards SM; Adair DC; Fasano A; McCowan LM; Guida M
    Am J Obstet Gynecol; 2023 Mar; 228(3):342.e1-342.e12. PubMed ID: 36075482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic Fluid and Maternal Serum Metabolic Signatures in the Second Trimester Associated with Preterm Delivery.
    Virgiliou C; Gika HG; Witting M; Bletsou AA; Athanasiadis A; Zafrakas M; Thomaidis NS; Raikos N; Makrydimas G; Theodoridis GA
    J Proteome Res; 2017 Feb; 16(2):898-910. PubMed ID: 28067049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and Amniotic Fluid Metabolic Profile Changes in Response to Gestational Diabetes Mellitus and the Association with Maternal-Fetal Outcomes.
    Zhou Y; Zhao R; Lyu Y; Shi H; Ye W; Tan Y; Li R; Xu Y
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing.
    Wang J; Chen L; Zhou C; Wang L; Xie H; Xiao Y; Zhu H; Hu T; Zhang Z; Zhu Q; Liu Z; Liu S; Wang H; Xu M; Ren Z; Yu F; Cram DS; Liu H
    Am J Obstet Gynecol; 2018 Sep; 219(3):287.e1-287.e18. PubMed ID: 29852155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.
    Nyberg DA; Luthy DA; Cheng EY; Sheley RC; Resta RG; Williams MA
    Am J Obstet Gynecol; 1995 Oct; 173(4):1030-5. PubMed ID: 7485289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis.
    Leruez-Ville M; Stirnemann J; Sellier Y; Guilleminot T; Dejean A; Magny JF; Couderc S; Jacquemard F; Ville Y
    Am J Obstet Gynecol; 2016 Sep; 215(3):342.e1-9. PubMed ID: 27063062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
    Drummond CL; Gomes DM; Senat MV; Audibert F; Dorion A; Ville Y
    Prenat Diagn; 2003 Dec; 23(13):1068-72. PubMed ID: 14691994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
    Sullivan A; Giudice T; Vavelidis F; Thiagarajah S
    Am J Obstet Gynecol; 1999 Aug; 181(2):260-5. PubMed ID: 10454666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prenatally diagnosed structural congenital anomalies.
    Gagnon A;
    J Obstet Gynaecol Can; 2009 Sep; 31(9):875-881. PubMed ID: 19941713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal abnormalities after ICSI in relation to semen parameters: results in 1114 fetuses and 1391 neonates from a single center.
    Belva F; Bonduelle M; Buysse A; Van den Bogaert A; Hes F; Roelants M; Verheyen G; Tournaye H; Keymolen K
    Hum Reprod; 2020 Sep; 35(9):2149-2162. PubMed ID: 32772109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
    Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.